Yisheng Intelligence Completes Series A Funding to Advance AI-Powered Medical Quality Enhancement
VCBeat (WeChat ID: vcbeat) has learned that Beijing Yisheng Intelligent Technology Co., Ltd. (hereinafter referred to as “Yisheng Intelligent”) recently announced the completion of its Series A financing round. This marks another round of funding following the company’s Pre-A round completed in early 2021. The Series A round was led by Weidu Venture Capital, which focuses on the healthcare sector, with existing investor Yuanyi Capital continuing to participate. Beituo Capital served as the financial advisor for this transaction.
Against the backdrop of China’s nationwide promotion of DRG/DIP-based medical insurance payment reforms and the high-quality development of public hospitals, Yisheng Intelligent, the pioneer and leader in the AI-driven medical record quality control sector, is ushering in a significant period of growth opportunity. Following the completion of this round of financing, Yisheng Intelligent will continue to enhance its products and expand its market presence, deepening its commitment to the sector of AI-empowered healthcare quality improvement.
In June this year, the General Office of the State Council issued the "Opinions on Promoting High-Quality Development of Public Hospitals," clearly stating that public hospitals must shift their development model from scale expansion to quality improvement and efficiency enhancement, transition their operational mode from extensive management to refined management, and reallocate resources with a greater emphasis on talent and technological factors rather than material elements. Evidently, at this new starting point for high-quality development, enhancing medical quality and efficiency will become the core logic guiding the future growth of hospitals. Yisheng Intelligence is positioned to leverage innovative AI technologies to empower improvements in medical quality, thereby supporting hospitals in achieving refined management and high-quality development.Zhou Yutong, Founder & CEO of Yisheng Intelligence, believes thatProviding high-quality medical services is the essential attribute of a hospital. Helping hospitals improve medical quality is a universal and rigid demand in their survival and development.
With the implementation of policies in recent years, such as performance assessments for public hospitals and healthcare insurance payment reforms based on DRG/DIP, there are increasingly stringent requirements for hospital medical quality, particularly medical record quality. However, hospitals themselves face a shortage of clinical physicians, and there is an even more significant gap in professionals who possess both clinical expertise and coding proficiency. To address this substantial challenge, Yisheng Intelligence has pioneered a new frontier through artificial intelligence technology.
Four years ago, Yisheng Intelligence pioneered the application of artificial intelligence technology to medical record quality control and management, and has continuously refined and upgraded its products. Yisheng Intelligence not only possesses a quality-control-grade NLP medical knowledge engine, but more importantly, through continuous training of AI, enables AI models to continuously learn and understand the medical logic within medical records, thereby extending intrinsic quality control capabilities to cover the entire lifecycle of medical records, including the ongoing, quasi-final, and final stages of diagnosis and treatment.
Founder Zhou Yutong holds a master’s degree from University College London (UCL), specializing in Artificial Intelligence Engineering. He studied under Professor Jun Wang, Chair Professor at the UCL Department of Computer Science, and received instruction from notable figures such as Professor David Silver, a core member of the AlphaGo team; Professor Emine Yilmaz, Chair of the SIGIR Program Committee and a Turing Research Fellow at UCL; among others. UCL is one of the world’s leading AI research institutions, with many key members of the renowned AlphaGo/DeepMind team hailing from UCL.
Beijing Yisheng Intelligent Technology Co., Ltd. entered the AI-driven medical record quality control sector four years ago, driven by its recognition of the fundamental need for hospitals to enhance medical care quality and its understanding that medical records serve as the infrastructure for healthcare quality.
Over the past four years, the state has successively issued various policies on hospital management assessment and medical insurance payment, elevating the quality of medical records to an unprecedented level, which aligns closely with the development direction of Yisheng Intelligent.
Zhou Yutong stated,The healthcare industry is inherently slow-paced, and leveraging AI to enhance medical quality is an even more meticulous and time-consuming endeavor. Only artificial intelligence models equipped with genuine comprehension and “reasoning” capabilities can deliver practical value and truly assist hospitals. However, enabling AI models to master the vast and complex domains of medicine and medical coding—particularly to understand the clinical logic embedded in medical records—is no easy task. It demands core technological expertise, a profound understanding of medical science, continuous collaboration with clinicians for product optimization, and sufficient time to refine the solution.
“To enter this sector and develop a truly useful AI-powered medical record quality control product, one must go through this process and invest the corresponding amount of time. Having started early, we have already successfully navigated this process ahead of others.”Zhou Yutong said.
Yisheng Intelligent has effectively defined the industry standard for “clinical adoption rate” in AI-driven medical record quality control. Its AI-based medical record quality control solution has delivered outstanding results at China’s top-tier tertiary hospitals, significantly improving medical record quality across multiple institutions.
At a Grade A tertiary hospital in western China, Yisheng AI increased the rate of Class A medical records from 63% to over 90% within six months. Currently, Yisheng Intelligent has not only refined its “connotation-level” AI-powered medical record quality control product but also validated hospitals’ actual needs and its business model. This round of financing will enable Yisheng Intelligent to further expand its market presence and apply its leading medical artificial intelligence technologies to more dimensions and scenarios of healthcare quality improvement.
In November this year, the National Healthcare Security Administration released the "Three-Year Action Plan for DRG/DIP Payment Method Reform."Wang Leilei, Partner at Weidu Ventures, believes thatAgainst the backdrop of the vigorous implementation of DRG/DIP health insurance payment policies, hospitals face significantly higher demands for refined management capabilities, making medical record quality control a critical factor influencing hospital revenue. Within this framework, intrinsic quality control of medical records serves as the core component, fundamentally addressing issues in medical record quality management. This approach enables hospitals to enhance efficiency and reduce costs through improved management, thereby generating substantial economic and social value.
Meanwhile, quality control of the intrinsic content of medical records represents the most technically challenging aspect with the highest barriers to entry. The Yisheng Intelligent team has dedicated four years to meticulously refining its technology and products, successfully applying artificial intelligence to complex scenarios involving the intrinsic content of medical records. This achievement truly integrates technology and products with clinical needs, which is key to how innovative technologies such as AI genuinely empower healthcare.
The product generated economic benefits ranging from several million to tens of millions of RMB for hospitals within a short period, enhanced the level of refined hospital management, and received consistent acclaim from hospital presidents.
“We believe that Yisheng Intelligent is an industry leader in this nascent, blue-ocean sector and is poised for explosive growth driven by the DRG/DIP reforms.”Wang Leilei said.
Tang Yinan, Investment Director at Yuanyi Capital, stated:“Yuan Yi is honored to have witnessed the solid growth of Yisheng Intelligence’s products and team over the past three years, and has continuously increased its investment through three consecutive funding rounds. Yuan Yi firmly believes in Yisheng’s position as a pioneer and leader in the AI-driven medical record quality control sector, leveraging innovative technologies to effectively address the core challenges of healthcare insurance reform. By delivering significant value in healthcare insurance payment and medical quality management to hospital clients, Yisheng demonstrates sustained commercial value.”
“AI-driven medical record quality control is just the beginning. Improving healthcare quality is, at its core, a management issue. Our medical AI capabilities not only empower medical record quality control but will also deliver value across broader scenarios in hospital management and healthcare quality improvement.”Zhou Yutong said.
UCL’s “AI for People and Planet” vision has consistently influenced Zhou Yutong. He believes that artificial intelligence still holds numerous application scenarios and untapped value in the healthcare industry, but realizing this potential requires a deep understanding of medicine, down-to-earth and patient research, and the identification of the true needs driving medical advancement and hospital management.
Yisheng Intelligence will continue to deepen its expertise in this sector, serving the healthcare industry.